These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 24440569

  • 1. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y, Li Z, He Y, Shang D, Pan J, Wang H, Chen H, Zhu Z, Wan L, Wang X.
    Toxicol Appl Pharmacol; 2014 Mar 01; 275(2):176-81. PubMed ID: 24440569
    [Abstract] [Full Text] [Related]

  • 2. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
    Kleuser B, Malek D, Gust R, Pertz HH, Potteck H.
    Mol Pharmacol; 2008 Dec 01; 74(6):1533-43. PubMed ID: 18768737
    [Abstract] [Full Text] [Related]

  • 3. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ, Quinn JA, Frackelton AR, Bland KI.
    Mol Endocrinol; 2002 Jan 01; 16(1):70-84. PubMed ID: 11773440
    [Abstract] [Full Text] [Related]

  • 4. Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway.
    Shang D, Li Z, Zhu Z, Chen H, Zhao L, Wang X, Chen Y.
    Oncol Rep; 2015 Apr 01; 33(4):2077-85. PubMed ID: 25672442
    [Abstract] [Full Text] [Related]

  • 5. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ, Quinn JA, Bland KI, Frackelton AR.
    Mol Endocrinol; 2000 Oct 01; 14(10):1649-60. PubMed ID: 11043579
    [Abstract] [Full Text] [Related]

  • 6. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y, Birnbaumer L, Teng CT.
    Mol Endocrinol; 2010 May 01; 24(5):969-80. PubMed ID: 20211987
    [Abstract] [Full Text] [Related]

  • 7. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    Tsai CL, Wu HM, Lin CY, Lin YJ, Chao A, Wang TH, Hsueh S, Lai CH, Wang HS.
    PLoS One; 2013 May 01; 8(9):e72999. PubMed ID: 24039841
    [Abstract] [Full Text] [Related]

  • 8. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C, Liao Y, Fan S, Tang H, Jiang Z, Zhou B, Xiong J, Zhou S, Zou M, Wang J.
    Med Oncol; 2015 Apr 01; 32(4):104. PubMed ID: 25744245
    [Abstract] [Full Text] [Related]

  • 9. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
    Zhou K, Sun P, Zhang Y, You X, Li P, Wang T.
    Steroids; 2016 Jul 01; 111():113-120. PubMed ID: 26850467
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V, Gougelet A, Maillard S, Renoir JM.
    Mol Endocrinol; 2003 Oct 01; 17(10):2013-27. PubMed ID: 12855746
    [Abstract] [Full Text] [Related]

  • 12. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y.
    Oncol Rep; 2012 Feb 01; 27(2):504-10. PubMed ID: 22075757
    [Abstract] [Full Text] [Related]

  • 13. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC.
    Cancer Res; 2010 Feb 01; 70(3):1184-94. PubMed ID: 20086172
    [Abstract] [Full Text] [Related]

  • 14. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
    Diel P, Olff S, Schmidt S, Michna H.
    J Steroid Biochem Mol Biol; 2002 Jan 01; 80(1):61-70. PubMed ID: 11867264
    [Abstract] [Full Text] [Related]

  • 15. 4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells.
    Li Y, Chen Y, Zhu ZX, Liu XH, Yang L, Wan L, Lei TW, Wang XD.
    Toxicology; 2013 Jul 05; 309():61-5. PubMed ID: 23624423
    [Abstract] [Full Text] [Related]

  • 16. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M.
    Cancer Res; 2007 Feb 15; 67(4):1859-66. PubMed ID: 17308128
    [Abstract] [Full Text] [Related]

  • 17. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
    Thomas P, Pang Y, Filardo EJ, Dong J.
    Endocrinology; 2005 Feb 15; 146(2):624-32. PubMed ID: 15539556
    [Abstract] [Full Text] [Related]

  • 18. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG.
    Cancer Res; 2004 Jul 01; 64(13):4637-47. PubMed ID: 15231676
    [Abstract] [Full Text] [Related]

  • 19. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
    Yang F, Xie HY, Yang LF, Zhang L, Zhang FL, Liu HY, Li DQ, Shao ZM.
    Autophagy; 2020 Jun 01; 16(6):1061-1076. PubMed ID: 32401166
    [Abstract] [Full Text] [Related]

  • 20. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes.
    Ikeda Y, Tajima S, Izawa-Ishizawa Y, Kihira Y, Ishizawa K, Tomita S, Tsuchiya K, Tamaki T.
    PLoS One; 2012 Jun 01; 7(7):e40465. PubMed ID: 22792339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.